SFDA: 83% growth in clinical research for biotechnology products in 2025

SFDA: 83% growth in clinical research for biotechnology products in 2025 SFDA: 83% growth in clinical research for biotechnology products in 2025

Saudi Gazette reportRIYADH — Saudi Arabia recorded a significant 83 percent growth in the number of clinical trial applications submitted to the Saudi Food and Drug Authority (SFDA) for advanced therapies

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement